Literature DB >> 35449495

Comparison of isolated respiratory and extrarespiratory mucormycosis: a 21-year observational study of 44 cases.

Hyeonji Seo1,2, Hyo-Ju Son3, Sungim Choi4, Jiwon Jung1, Min Jae Kim1, Yong Pil Chong1, Joon Seon Song5, Sang-Oh Lee1, Sang-Ho Choi1, Yang Soo Kim1, Sung-Han Kim6.   

Abstract

OBJECTIVES: This study aimed to compare the clinical characteristics and outcomes of patients with isolated respiratory and extrarespiratory mucormycosis.
METHODS: Adult patients diagnosed with proven or probable invasive mucormycosis in a tertiary hospital in South Korea, between 1999 and 2020 were retrospectively reviewed. We compared the clinical, mycological characteristics, and outcomes of patients with isolated respiratory mucormycosis (IRM) and those with extrarespiratory mucormycosis (ERM).
RESULTS: A total of 44 patients including 32 (72%) with IRM, and 12 (27%) with ERM were enrolled. Of these, 38 (86%) were classified as proven and 6 (14%) as probable invasive mucormycosis according to the EORTC/MSG criteria. Univariate analysis exhibited that old age, surgery, and intensive care unit were associated with ERM, and multivariable analysis revealed that variable associated with ERM was intensive care unit (aOR 9.80; 95% CI 2.07-46.35; P = 0.004). There were no significant differences in 90-day mortality between patients with IRM and ERM (38% vs 50%, P = 0.45). In multivariable analysis, neutropenia (aOR 6.88; 95% CI 1.67-28.27; P = 0.01) was an independent risk factor for 90-day mortality.
CONCLUSIONS: More than a quarter of patients with mucormycosis had extrarespiratory manifestations, especially in patients who were admitted to intensive care unit. The mortality of the patients with ERM was comparable to that of the patients with IRM, although the patients with ERM received ICU care more frequently.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.

Entities:  

Keywords:  Central nervous system; Extrarespiratory; Gastrointestinal; Mortality; Mucormycosis

Mesh:

Substances:

Year:  2022        PMID: 35449495     DOI: 10.1007/s15010-022-01831-w

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   7.455


  1 in total

1.  Using immunohistochemistry to assess the accuracy of histomorphologic diagnosis of aspergillosis and mucormycosis.

Authors:  Jiwon Jung; Young Soo Park; Heungsup Sung; Joon Seon Song; Sang-Oh Lee; Sang-Ho Choi; Yang Soo Kim; Jun Hee Woo; Sung-Han Kim
Journal:  Clin Infect Dis       Date:  2015-08-03       Impact factor: 9.079

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.